Bentham Science Logo

Track Your Manuscript:


Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 22, 4 Issues, 2022
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access

Contents

Cardiovascular & Hematological Disorders-Drug Targets , Volume 16 - Number 1







Review Article

Idarucizumab: Clinical Role of a Novel Reversal Agent for Dabigatran

, 16(1): 25 - 29

Mohamed Teleb, Kevin Salire, Miraie Wardi, Haider Alkhateeb, Sarmad Said and Debabrata Mukherjee


DOI: 10.2174/1871529X16666160701112448



Research Article



Research Article




Editor-in-Chief

Garry X. Shen
Department of Internal Medicine
University of Manitoba
Winnipeg, MB
(Canada)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Cardiovascular and Hematological Disorders-drug Targets was launched in 2001. Dr. Garry X. Shen serves as the Editor-in-Chief of the journal.
New eBook

Frontiers in Clinical Drug Research-Hematology



You can view the contents of this eBook [here] or purchase it [here].

Related Journals

Related eBooks

eBooks Catalog